Alpenglow Biosciences logo

Alpenglow Biosciences

alpenglowbiosciences.com

Alpenglow Biosciences provides AI-enabled 3D tissue imaging, digital pathology, and spatial profiling solutions for researchers and clinical teams. Its platform combines light-sheet microscopy, automated volumetric data processing, and AI-powered analysis to quantify cells, structures, and spatial relationships in intact tissue samples, supporting drug development, diagnostics, and biomarker discovery. The organization aims to advance biological insight and clinical diagnostics by enabling comprehensive analysis of tissue biology.

Facts

HQ
Seattle, Washington, USA
Sectors
Biotechnology Research
Founded
2018
Employees
50
Registered name
Alpenglow Biosciences
Members see funding amounts.
.
Founders
Nicholas Reder, Jonathan Liu, Adam Glaser, Larry True

Is this your organization? Claim it

Recent coverage

Front-page news, podcasts and videos about Alpenglow Biosciences

See all 7

Phase Genomics Secures $2.5M to Develop AI Platform for Detecting Cancer Chromosomal Aberrations

Seattle startup Phase Genomics received $2.5 million in funding, including $2 million from the U.S. National Cancer Institute and $500,000 from Washington state's Andy Hill CARE Fund, to advance its AI-driven platform that detects chromosomal aberrations in cancer. The funding supports projects analyzing tumor samples to develop predictive scores for cancers like acute myeloid leukemia and colorectal cancer.

People

See all 4
  • Nicholas Reder
    Nicholas Reder Executive Officer, Director, CEO, Founder & Co-Inventor
  • Adam Glaser Co-founder
  • Jonathan Liu Co-founder

Online

Questions about Alpenglow Biosciences

What is Alpenglow Biosciences?

Alpenglow Biosciences is a startup based in Seattle, Washington, USA that provides AI-enabled 3D tissue imaging, digital pathology, and spatial profiling for researchers and clinical teams.

What is Alpenglow Biosciences known for?

Alpenglow Biosciences combines light-sheet microscopy, automated volumetric data processing, and AI analysis to quantify cells, structures, and spatial relationships in intact tissue for drug development, diagnostics, and biomarker discovery.

What has Alpenglow Biosciences been in the news for?

GeekWire reported in March 2026 that Alpenglow Biosciences was among its Innovation of the Year finalists. In January 2026, GeekWire reported that Alpenglow Biosciences partnered with PathNet to commercialize 3D microscope technology for cancer diagnostics.

Who are the people behind Alpenglow Biosciences?

Nicholas Reder is CEO, executive officer, founder and co-inventor of Alpenglow Biosciences. Adam Glaser, Jonathan Liu and Lawrence True are co-founders.

Who invested in Alpenglow Biosciences, and how much has it raised?

Members of Seattle Flow see Alpenglow Biosciences' funding rounds, amounts and investors on its Funding tab. Joining is free.

Where is Alpenglow Biosciences based?

Alpenglow Biosciences is based in Seattle, Washington, USA.